Study title: Long term double blind controlled studies in children
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Urigenital diseases | |||||
Brands: | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: OXYBUTYNIN | |||||
ATC code: G04BD04 | |||||
Document link: Oxybutynin STUDY Marion 012-059.xls | |||||
Document date: 2013-06-04 | |||||
Study number: 012-059 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |